Susquehanna International Group, LLP Xeris Biopharma Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 107,344 shares of XERS stock, worth $402,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,344
Previous 79,915
34.32%
Holding current value
$402,540
Previous $227,000
59.91%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$38.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$10.8 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $510M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...